Pioneering biomedical executive Alfred E. Mann and a panel of experts will share their views and visions for the future of the industry at a Valencia Gateway business conference on Oct. 30.
The conference, hosted by The Newhall Land and Farming Co., will look at the future of the industry and how it is expected to change in Southern California.
Mann is chairman and chief executive officer of MannKind Corp., a diversified biopharmaceutical company. MannKind focuses on the development of novel therapeutics and drug delivery technologies.
Other panelists will include Jeffrey H. Greiner, president of Valencia-based Advanced Bionics Corp.; Dr. Stephen J. McCormack, president of AlleCure Corp.; and John Simard, president of CTL ImmunoTherapies Corp.
Attending the conference will be representatives from the growing biomedical industry, licensing and technology professionals, investment advisors and venture capitalists, as well as executive search and real estate professionals.
“We are pleased to host this conference as Valencia (continues) to show impressive economic development and (is) quickly becoming an attractive industry cluster for the Southern California biomedical community,” sand Newhall Land President Gary Cusumano in a statement. “Biomed is an important element of our business community, as well as for Valencia and the Santa Clarita Valley as a whole, and we see no end to its potential growth and continued success here.”
For reservations to the conference call 255-4284 by Oct. 26. The cost is $30 in advance or $40 at the door, and includes lunch.
—The Signal
